Obesity Phenotypes and Its Relation to Cardiovascular Diseases
NCT ID: NCT06092021
Last Updated: 2023-10-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2023-10-31
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Primary Outcomes:
1- To examine the association between different obesity phenotypes and cardiovascular diseases.by using echocardiography, lipid profile
* Secondary Outcomes:
1. frequency of obesity phenotypes on our locality
2. Correlation between each type of obesity phenotypes and other metabolic disturbances (e.g. DM, dyslipidemia, NASH)
3. Correlation between epcardial fat, carotid intimal thickness and different obesity phenotypes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Obesity Paradox in Non Valvular Atrial Fibrillation Regarding Outcomes: Fact or Fiction
NCT03904329
A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change
NCT07239167
Echocardiography, Adherence to Mediterranean Diet (AMDS) and Physical Exercise in Fatty Liver
NCT02669316
Obeservational Cohort for Evaluating Future Cardiovascular Disease With High Metabolic Risks
NCT06385431
Association of Obesity and Cardiovascular Outcomes in Hypertrophic Cardiomyopathy
NCT05645939
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2- Pregnant females.
3- Patients with congenital heart diseases.
4- Patients with previous bariatric surgery.
5-Patients with type 1 DM.
6-Patients with hereditary hyperlipidemia
.Secondary causes of obesity
include these:Endocrine DisordersCushing SyndromeHypothyroidismPseudohypoparathyroidismType 2 diabetes
Genetic SyndromesPrader-Willi syndromeBardet-Biedel syndromeCohen syndromeCentral Nervous System DisordersHypothalamic TumorTrauma to or inflammation of the hypothalamic regionOtherDrug induced - atypical anti-psychotics, tricyclic antidepressantsBinge eating disorderBulimia nervosa
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Asmaa Khaled Sayed
Asmaa khaled sayed
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Asmaa Sayed, Resident
Role: PRINCIPAL_INVESTIGATOR
Assiut University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asmaa khaled sayed
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Vecchie A, Dallegri F, Carbone F, Bonaventura A, Liberale L, Portincasa P, Fruhbeck G, Montecucco F. Obesity phenotypes and their paradoxical association with cardiovascular diseases. Eur J Intern Med. 2018 Feb;48:6-17. doi: 10.1016/j.ejim.2017.10.020.
Piche ME, Tchernof A, Despres JP. Obesity Phenotypes, Diabetes, and Cardiovascular Diseases. Circ Res. 2020 May 22;126(11):1477-1500. doi: 10.1161/CIRCRESAHA.120.316101. Epub 2020 May 21.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Cardiovascular obesity
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.